Attovia Therapeutics, Inc.(ATTO)
$16.73+0.09 (+0.54%)
ATTO
Attovia Therapeutics, Inc. financials statements
$16.73
At close:+0.09 (+0.54%)
Want to see ATTO full AI Analyst Report?
Attovia Therapeutics, Inc. (ATTO) Ratios
13 Followers
Attovia Therapeutics, Inc. Ratios
ATTO's free cash flow for Q3 2026 was $-25.69M. For the 2026 fiscal year, ATTO's free cash flow was decreased by $-17.00K and operating cash flow was $-25.67M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 14.20 | 9.39 | ― | ― | ― |
| Quick Ratio | 14.20 | 9.39 | ― | ― | ― |
| Cash Ratio | 3.65 | 3.97 | ― | ― | ― |
| Solvency Ratio | -3.96 | -2.71 | ― | ― | ― |
| Operating Cash Flow Ratio | -5.38 | -4.54 | ― | ― | ― |
| Short-Term Operating Cash Flow Coverage | -30.82 | 0.00 | ― | ― | ― |
| Net Current Asset Value | $ 141.19M | $ 57.89M | ― | ― | ― |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.03 | 0.00 | ― | ― | ― |
| Debt-to-Equity Ratio | 0.03 | 0.00 | ― | ― | ― |
| Debt-to-Capital Ratio | 0.03 | 0.00 | ― | ― | ― |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | ― | ― | ― |
| Financial Leverage Ratio | 1.10 | 1.23 | ― | ― | ― |
| Debt Service Coverage Ratio | -34.54 | 0.00 | ― | ― | ― |
| Interest Coverage Ratio | 0.00 | 0.00 | ― | ― | ― |
| Debt to Market Cap | 0.00 | 0.00 | ― | ― | ― |
| Interest Debt Per Share | 0.12 | 0.00 | ― | ― | ― |
| Net Debt to EBITDA | 0.53 | 0.74 | ― | ― | ― |
| Profitability Margins | |||||
| Gross Profit Margin | 40.44% | 0.00% | ― | ― | ― |
| EBIT Margin | -4974.74% | 0.00% | ― | ― | ― |
| EBITDA Margin | -4915.19% | 0.00% | ― | ― | ― |
| Operating Profit Margin | -4974.74% | 0.00% | ― | ― | ― |
| Pretax Profit Margin | -4490.89% | 0.00% | ― | ― | ― |
| Net Profit Margin | -4490.89% | 0.00% | ― | ― | ― |
| Continuous Operations Profit Margin | -4490.89% | 0.00% | ― | ― | ― |
| Net Income Per EBT | 100.00% | 100.00% | ― | ― | ― |
| EBT Per EBIT | 90.27% | 95.78% | ― | ― | ― |
| Return on Assets (ROA) | -36.55% | -51.88% | ― | ― | ― |
| Return on Equity (ROE) | -40.21% | -64.06% | ― | ― | ― |
| Return on Capital Employed (ROCE) | -43.36% | -60.23% | ― | ― | ― |
| Return on Invested Capital (ROIC) | -42.83% | -60.23% | ― | ― | ― |
| Return on Tangible Assets | -36.55% | -51.88% | ― | ― | ― |
| Earnings Yield | -6.43% | -4.22% | ― | ― | ― |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | ― | ― | ― |
| Payables Turnover | 0.23 | 0.08 | ― | ― | ― |
| Inventory Turnover | 0.00 | 0.00 | ― | ― | ― |
| Fixed Asset Turnover | 0.17 | 0.00 | ― | ― | ― |
| Asset Turnover | 0.01 | 0.00 | ― | ― | ― |
| Working Capital Turnover Ratio | 0.01 | 0.00 | ― | ― | ― |
| Cash Conversion Cycle | -1612.08 | -4827.79 | ― | ― | ― |
| Days of Sales Outstanding | 0.00 | 0.00 | ― | ― | ― |
| Days of Inventory Outstanding | 0.00 | 0.00 | ― | ― | ― |
| Days of Payables Outstanding | 1612.08 | 4827.79 | ― | ― | ― |
| Operating Cycle | 0.00 | 0.00 | ― | ― | ― |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.38 | -0.81 | ― | ― | ― |
| Free Cash Flow Per Share | -1.43 | -0.86 | ― | ― | ― |
| Dividend Paid and CapEx Coverage Ratio | -25.59 | -19.77 | ― | ― | ― |
| Capital Expenditure Coverage Ratio | -25.59 | -19.77 | ― | ― | ― |
| Operating Cash Flow Coverage Ratio | -11.25 | 0.00 | ― | ― | ― |
| Operating Cash Flow to Sales Ratio | -43.85 | 0.00 | ― | ― | ― |
| Free Cash Flow Yield | -6.53% | -3.91% | ― | ― | ― |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -15.42 | -20.86 | ― | ― | ― |
| Price-to-Sales (P/S) Ratio | 698.03 | 0.00 | ― | ― | ― |
| Price-to-Book (P/B) Ratio | 6.25 | 15.17 | ― | ― | ― |
| Price-to-Free Cash Flow (P/FCF) Ratio | -15.32 | -25.60 | ― | ― | ― |
| Price-to-Operating Cash Flow Ratio | -15.92 | -26.90 | ― | ― | ― |
| Price-to-Earnings Growth (PEG) Ratio | -0.44 | 0.00 | ― | ― | ― |
| Enterprise Value Multiple | -13.67 | -22.11 | ― | ― | ― |
| Enterprise Value | 907.40M | 911.70M | ― | ― | ― |
| EV to EBITDA | -13.67 | -22.11 | ― | ― | ― |
| EV to Sales | 672.15 | 0.00 | ― | ― | ― |
| EV to Free Cash Flow | -14.75 | -24.77 | ― | ― | ― |
| EV to Operating Cash Flow | -15.33 | -26.02 | ― | ― | ― |
| Tangible Book Value Per Share | 3.50 | 1.44 | ― | ― | ― |
| Shareholders’ Equity Per Share | 3.50 | 1.44 | ― | ― | ― |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | ― | ― | ― |
| Revenue Per Share | 0.03 | 0.00 | ― | ― | ― |
| Net Income Per Share | -1.41 | -0.92 | ― | ― | ― |
| Tax Burden | 1.00 | 1.00 | ― | ― | ― |
| Interest Burden | 0.90 | 0.96 | ― | ― | ― |
| Research & Development to Revenue | 40.11 | 0.00 | ― | ― | ― |
| SG&A to Revenue | 10.04 | 0.00 | ― | ― | ― |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | ― | ― | ― |
| Income Quality | 0.97 | 0.78 | ― | ― | ― |
Currency in USD
